Literature DB >> 10492378

Targeting of transferrin receptors in nude mice bearing A431 and LS174T xenografts with [18F]holo-transferrin: permeability and receptor dependence.

L Aloj1, E Jogoda, L Lang, C Caracò, R D Neumann, C Sung, W C Eckelman.   

Abstract

UNLABELLED: The goal of this study was to investigate whether 18F-labeled transferrin (Tf), which has a molecular weight (Mr) of approximately 79,000, binds to Tf receptor sites in tumors in a specific manner within the time frame commensurate with the half-life of 18F (109.7 min). We have previously shown that [18F]holo-Tf ([18F]Tf) maintains all properties of native Tf in vitro and that it can specifically target liver Tf receptor sites in vivo.
METHODS: The distribution of [18F]Tf, using [18F]albumin (Alb) or [14C]Alb as a control, was studied over a 6-h period in nude mice bearing LS174T and A431 xenografts of a high- and low-permeability tumor, respectively.
RESULTS: Measurements of Tf receptor concentration in the tumor extracts suggest similar binding capacities. In vivo, liver uptake values were higher for [18F]Tf than for both [18F]Alb and [14C]Alb throughout the study, indicating specific binding. In contrast, tumor Tf uptake values remained below those of the Alb tracers, and tumor-to-blood ratios of [18F]Tf in each xenograft increased in parallel with those of the Alb tracers. The permeabilities of [14C]Alb and [18F]Tf in LS174T were calculated to be 1.29+/-0.49 and 1.03+/-0.38 microL/min/g (mean +/- SD), respectively, whereas the permeabilities of the two tracers in A431 were 0.79+/-0.24 and 0.44+/-0.04 microL/min/g. Pharmacokinetic modeling of the data using these permeabilities and the high plasma and extracellular concentrations of endogenous Tf showed that the observed uptake values in the two xenografts are consistent with a non-receptor-mediated distribution. In the liver, the absence of permeability barriers yields specific [18F]Tf binding to receptors compared with the [14C]Alb control, within 5 min after injection.
CONCLUSION: Receptor-mediated accumulation of [18F]Tf in tumor xenografts is impaired by rate-determining permeability and competition from endogenous Tf and is not achieved in a time frame of 6 h.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10492378

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  8 in total

1.  Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals.

Authors:  Brian M Zeglis; Jacob L Houghton; Michael J Evans; Nerissa Viola-Villegas; Jason S Lewis
Journal:  Inorg Chem       Date:  2013-12-06       Impact factor: 5.165

2.  High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment.

Authors:  A M Wu; P J Yazaki; S w Tsai; K Nguyen; A L Anderson; D W McCarthy; M J Welch; J E Shively; L E Williams; A A Raubitschek; J Y Wong; T Toyokuni; M E Phelps; S S Gambhir
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

3.  In vitro cellular uptake and dimerization of signal transducer and activator of transcription-3 (STAT3) identify the photosensitizing and imaging-potential of isomeric photosensitizers derived from chlorophyll-a and bacteriochlorophyll-a.

Authors:  Avinash Srivatsan; Yanfang Wang; Penny Joshi; Munawwar Sajjad; Yihui Chen; Chao Liu; Krishnakumar Thankppan; Joseph R Missert; Erin Tracy; Janet Morgan; Nestor Rigual; Heinz Baumann; Ravindra K Pandey
Journal:  J Med Chem       Date:  2011-09-06       Impact factor: 7.446

4.  Inhibition of transferrin iron release increases in vitro drug carrier efficacy.

Authors:  Bert J Lao; Wen-Lin P Tsai; Foad Mashayekhi; Edward A Pham; Anne B Mason; Daniel T Kamei
Journal:  J Control Release       Date:  2006-12-08       Impact factor: 9.776

5.  Novel PAMAM-PEG-Peptide Conjugates for siRNA Delivery Targeted to the Transferrin and Epidermal Growth Factor Receptors.

Authors:  Koldo Urbiola; Laura Blanco-Fernández; Manfred Ogris; Wolfgang Rödl; Ernst Wagner; Conchita Tros de Ilarduya
Journal:  J Pers Med       Date:  2018-01-09

Review 6.  Measuring oncogenic signaling pathways in cancer with PET: an emerging paradigm from studies in castration-resistant prostate cancer.

Authors:  Michael J Evans
Journal:  Cancer Discov       Date:  2012-10-05       Impact factor: 39.397

7.  Annotating MYC status with 89Zr-transferrin imaging.

Authors:  Jason P Holland; Michael J Evans; Samuel L Rice; John Wongvipat; Charles L Sawyers; Jason S Lewis
Journal:  Nat Med       Date:  2012-09-23       Impact factor: 53.440

8.  Non-invasive in vivo imaging of near infrared-labeled transferrin in breast cancer cells and tumors using fluorescence lifetime FRET.

Authors:  Ken Abe; Lingling Zhao; Ammasi Periasamy; Xavier Intes; Margarida Barroso
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.